Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator

Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator

The subcutaneous implantable cardioverter-defibrillator (S-ICD) was introduced to reduce acute transvenous leadrelated complications, such as pneumothorax, endocarditis, cardiac perforation, and lead dislodgements, as well as the complications related to chronic indwelling leads, such as lead failure, venous obstruction, and bacteremia. The standard implantation technique of the S-ICD involves ...

Subcutaneous implantable cardioverter-defibrillator.

or nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead. Traditional ICDs are implanted under the skin with the generator positioned beneath the collar bone. The defibrilla-tion lead is inserte...

Subcutaneous implantable cardioverter defibrillator.

Thoracoscopic implantation of the implantable cardioverter defibrillator.

(Chest 1993; 103:271-72) T he implantable cardioverter defibrillator (lCD) has become accepted treatment for the management of certain malignant ventricular arrhythmias. ‘ Implantation ofthe lCD usually requires an anterolateral thoracotomy through which the patch electrodes and sensing electrodes are placed, in either an intraor an extrapericardial position, although subcostal and subxiphoid a...

Subcutaneous implantable cardioverter-defibrillator (S-ICD).

Current state-of-the art implantable cardioverter-defibrillator (ICD) systems have been proven to be safe and effective in treating ventricular arrhythmias leading to cardiac death. ICDs require placement of at least one lead in, or on, the heart. Surgical placement under fluoroscopy and the ongoing presence of the transvenous leads within the patient's heart are associated with a significant p...